MediPharm Labs Corp. (TSX: LABS)
Canada flag Canada · Delayed Price · Currency is CAD
0.0650
0.00 (0.00%)
Dec 20, 2024, 2:27 PM EST

MediPharm Labs Balance Sheet

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2016
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2016
Cash & Equivalents
13.0917.9824.1534.1119.9138.63
Upgrade
Short-Term Investments
0.340.270.761.142.060.68
Upgrade
Cash & Short-Term Investments
13.4318.2524.935.2521.9739.31
Upgrade
Cash Growth
-5.64%-26.73%-29.36%60.46%-44.11%272.78%
Upgrade
Accounts Receivable
6.235.5212.3515.7227.7226.22
Upgrade
Other Receivables
0.470.350.661.26.411.32
Upgrade
Receivables
6.695.8713.0116.9234.1427.54
Upgrade
Inventory
9.059.897.7810.9822.1451.49
Upgrade
Prepaid Expenses
0.670.640.691.060.440.33
Upgrade
Other Current Assets
4.7320.981.342.841.04
Upgrade
Total Current Assets
34.5736.6347.3565.5581.52119.7
Upgrade
Property, Plant & Equipment
19.6325.2718.1125.8934.1442.23
Upgrade
Long-Term Investments
----0.190.19
Upgrade
Other Intangible Assets
0.91.030.040.040.23-
Upgrade
Long-Term Deferred Tax Assets
-----0.59
Upgrade
Other Long-Term Assets
0.751-0.882.156.12
Upgrade
Total Assets
55.8463.9465.592.36118.23168.83
Upgrade
Accounts Payable
3.512.133.542.995.5519.06
Upgrade
Accrued Expenses
5.134.913.674.159.253.14
Upgrade
Short-Term Debt
0.572.110.52---
Upgrade
Current Portion of Long-Term Debt
----7.381.46
Upgrade
Current Portion of Leases
0.050.120.080.110.320.36
Upgrade
Current Income Taxes Payable
-----4.73
Upgrade
Current Unearned Revenue
0.840.390.491.321-
Upgrade
Other Current Liabilities
0.661.211.150.310.750.1
Upgrade
Total Current Liabilities
10.7610.869.468.8824.2528.85
Upgrade
Long-Term Debt
----10.548.12
Upgrade
Long-Term Leases
0.040.070.030.10.220.64
Upgrade
Long-Term Unearned Revenue
---0.23--
Upgrade
Other Long-Term Liabilities
---04.81-
Upgrade
Total Liabilities
10.810.939.499.2239.8237.6
Upgrade
Common Stock
200.95200.24191.26190.55138.51122.81
Upgrade
Retained Earnings
-185.7-176.73-163.65-129.34-74.54-8.19
Upgrade
Comprehensive Income & Other
29.829.4928.421.9414.4516.93
Upgrade
Total Common Equity
45.0553.0156.0183.1578.41131.55
Upgrade
Minority Interest
------0.32
Upgrade
Shareholders' Equity
45.0553.0156.0183.1578.41131.23
Upgrade
Total Liabilities & Equity
55.8463.9465.592.36118.23168.83
Upgrade
Total Debt
0.652.30.630.2218.4610.58
Upgrade
Net Cash (Debt)
12.7815.9524.2735.043.5128.73
Upgrade
Net Cash Growth
10.98%-34.27%-30.73%897.86%-87.78%532.17%
Upgrade
Net Cash Per Share
0.030.040.090.140.030.21
Upgrade
Filing Date Shares Outstanding
411.12404.05282.16273.94257.95134.72
Upgrade
Total Common Shares Outstanding
411.07401.4282.16273.54155.55131.53
Upgrade
Working Capital
23.8125.7737.8956.6757.2890.86
Upgrade
Book Value Per Share
0.110.130.200.300.501.00
Upgrade
Tangible Book Value
44.1551.9755.9783.178.19131.55
Upgrade
Tangible Book Value Per Share
0.110.130.200.300.501.00
Upgrade
Land
1.862.811.521.861.891.86
Upgrade
Buildings
24.9727.8420.9324.7925.4918.25
Upgrade
Machinery
15.118.2417.4618.8818.4411.14
Upgrade
Construction In Progress
-2.52.64.493.2613.25
Upgrade
Leasehold Improvements
0.210.210.210.210.21-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.